XTX Topco Ltd Boosts Stake in Chemed Co. (NYSE:CHE)

XTX Topco Ltd lifted its holdings in shares of Chemed Co. (NYSE:CHE) by 111.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,843 shares of the company’s stock after buying an additional 1,499 shares during the period. XTX Topco Ltd’s holdings in Chemed were worth $1,709,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Cetera Advisors LLC bought a new stake in shares of Chemed in the first quarter worth approximately $267,000. GAMMA Investing LLC raised its stake in Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after buying an additional 22 shares during the last quarter. CWM LLC lifted its holdings in shares of Chemed by 18.5% during the 2nd quarter. CWM LLC now owns 397 shares of the company’s stock valued at $215,000 after buying an additional 62 shares during the period. OLD National Bancorp IN purchased a new position in shares of Chemed in the 2nd quarter worth $313,000. Finally, SG Americas Securities LLC grew its holdings in shares of Chemed by 422.9% in the second quarter. SG Americas Securities LLC now owns 7,551 shares of the company’s stock worth $4,097,000 after acquiring an additional 6,107 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. This trade represents a 1.89 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total transaction of $421,353.84. Following the transaction, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at $10,526,362.94. This trade represents a 3.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,845 shares of company stock worth $3,978,798 over the last three months. 3.32% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Royal Bank of Canada lowered their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th.

Chemed Price Performance

Shares of CHE stock opened at $552.62 on Friday. The company has a market cap of $8.32 billion, a price-to-earnings ratio of 27.92, a PEG ratio of 2.42 and a beta of 0.46. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62. The firm has a fifty day moving average price of $574.95 and a 200-day moving average price of $564.98.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. During the same period in the prior year, the firm posted $5.32 EPS. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. Equities research analysts expect that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.36%. The ex-dividend date of this dividend was Monday, November 18th. Chemed’s dividend payout ratio is currently 10.11%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.